Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
In a significant advancement for atopic dermatitis treatment, Sanofi Healthcare India Pvt. Ltd. has received approval for Dupixent® (dupilumab). This…